In contrast, Ctnnb1 (beta-catenin), Egfr and Pten mutations are associated with decreased CD8+ T cell infiltration in melanoma, non-small cell lung carcinoma and prostate cancer, respectively. This evidence concerns the gene CTNNB1 and non-small cell lung carcinoma.